Morepen receives USFDA approval for Montelukast Sodium
Morepen Laboratories has received USFDA approval for Montelukast Sodium, a bulk drug which is used in treatment of asthma and respiratory disorders. The drug market […]
FDA
Lupin receives USFDA approval for calcipotriene topical solution
Lupin Ltd has received final USFDA approval for its generic version of Dovonex scalp solution used in treatment of psoriasis of scalp. The drug calcipotriene […]
Cadila Healthcare receives USFDA approval for Ethacrynate sodium
Zydus Cadila has received final USFDA approval to market Ethacrynate sodium for injection, used to reduce swelling caused by various diseases. The company will market […]
Orchid Pharma receives USFDA approval for Airpiprazole
Orchid Pharma has received final USFDA approval for Aripiprazole Orally-Disintegrating tablets, used in treatment of schizophrenia and bipolar disorder. The drug will be made available […]
Zydus Cadila receives USFDA approval for minocycline hydrochloride
Zydus Cadila has received final USFDA approval to market minocycline hydrochloride extended release tablets used to treat acne. The company will market the drug in […]
Ajanta Pharma launches Clonidine Hydrochloride ER tablet in USA
Ajanta Pharma received US FDA approval and has launched Clonidine Hydrochloride Extended Release Tablets in the US Market through its wholly owned subsidiary Ajanta Pharma […]
Lupin receives USFDA approval for Nadolol
Lupin has received final USFDA approval to market generic Nadolol tablets, used for treatment of hypertension, in the American market. The drug will be marketed […]
Ajanta Pharma receives USFDA approval for Entacapone
Ajanta Pharma has received final USFDA approval for Entacapone tablets to market the same in USA. It is a bioequivalent generic version of Comtan tablets. […]
Ajanta Pharma launches eletriptan hydrobromide in USA
Ajanta Pharma has launched eletriptan hydrobromide tablets in the US market. The drug is a bioequivalent generic version of Relpax tablets and the company has […]
Jubilant Life Sciences has received USFDA approval for Indocin
Jubilant Life Sciences has received final USFDA approval for the generic version of its non-steroidal anti-inflammatory drug, Indocin. The approval for Indomethacin capsules is a […]